Host ribosomal translation machinery

The host ribosomal translation machinery is the fundamental cellular system responsible for the synthesis of proteins from messenger RNA (mRNA) templates. It is composed of the 80S ribosome—a large ribonucleoprotein complex consisting of 40S and 60S subunits—along with various auxiliary proteins known as translation initiation, elongation, and termination factors (Butnaru et al., 2017, Frontiers in Genetics). In many diseases, particularly cancer and viral infections, this machinery is dysregulated or hijacked to support rapid cell growth or the production of viral progeny (White et al., 2021, Science). For instance, many viruses lack their own translational apparatus and must utilize the host's ribosomes to translate viral mRNA, making the machinery a strategic target for broad-spectrum antiviral therapy (White et al., 2021, Science). In oncology, inhibitors targeting components like the eIF4F complex or the ribosomal A-site are used to suppress the translation of oncogenic proteins (PubChem, CID 208908; eFFECTOR Therapeutics, 2024). Because protein synthesis is essential for all living cells, therapeutic intervention requires careful targeting to achieve a therapeutic window, often by exploiting the heightened dependency of diseased cells on high translation rates (Butnaru et al., 2017, Frontiers in Genetics). Notable drugs interacting with this machinery include Omacetaxine mepesuccinate for leukemia and experimental agents like Zotatifin for solid tumors and viral infections (PubChem, CID 208908; eFFECTOR Therapeutics, 2024).

Other names

Eukaryotic ribosome80S ribosomeProtein synthesis machineryHost translation apparatusCytoplasmic translation machinery

Inhibition of protein synthesis through binding to the ribosomal subunits (e.g., the A-site of the 60S subunit) or by targeting essential translation initiation and elongation factors (e.g., eIF4A, eEF1A) to prevent the assembly, scanning, or movement of the translation complex along mRNA.